4 extractive question-and-answer pairs built from ICMR Standard Treatment Workflow (STW) FRAGILITY FRACTURES, published by icmr.gov.in. Every answer is a verbatim span of text the source prints, and each row carries the passage it sits in, its offset in that passage, the source quote, the page and the location in the document, so any row can be checked against the original. 1 of the 4 pairs (25.0%) are explanatory questions and 3 restate a figure. 100.00% of rows pass the corpus quality gate.
Use the API URL with your free DD token in notebooks, scripts, and pipelines.
https://www.desidata.in/api/datasets/icmr-standard-treatment-workflow-for-fragility-fractures-question-and-answer/downloadDataset downloads are free. For Python or API downloads, sign in once and create a free DD token; set it as DD_TOKEN or save it in your notebook's secrets. Requests are linked to your account so your download history and counts stay accurate.
# One-time install: pip install desidata
# Set DD_TOKEN in your environment first (create a free token in Profile & settings).
import desidata
df = desidata.load("icmr-standard-treatment-workflow-for-fragility-fractures-question-and-answer")
df.head()Sign in with Google to download.
Usable for analysis, but expect some cleaning before you rely on it.
Consensus Document on Management of Pancreatic Cancer - Question and Answer Dataset
Economy · 268 rows
ICMR Standard Treatment Workflow for Cataract - Question and Answer Dataset
Economy · 27 rows
Neurology Questions from P a R T N E R S - Question and Answer Dataset
Economy · 107 rows
Beginner's Guide for Systematic Reviews - Question and Answer Dataset
Economy · 407 rows
Annual Report 2015-16 by agriwelfare.gov.in - Question and Answer Dataset
Economy · 1,013 rows
Higher Education in India - Question and Answer Dataset
Economy · 1,594 rows
Gender Policy of NABARD - Question and Answer Dataset
Economy · 14 rows
ICAR Annual Report 2025-26 - Question and Answer Dataset
Economy · 1,101 rows
First 4 of 4 rows
| question | answer | context | answer_start | question_type | knowledge_quality_score | source_quote | source_page | source_location | confidence | validation_status |
|---|---|---|---|---|---|---|---|---|---|---|
| What are some examples of fractures associated with minor trauma? | fracture neck of femur, forearm fracture (Colle’s), vertebral fracture | Ultrasound abdomen, gall stones, renal stones and nephrocalcinosis, Ultrasound neck, enlarged parathyroid Sestamibi scan for parathyroid enlargement • To be suspected in fractures resulting from trivial trauma or fall from a standing height or less • For example fracture neck of femur, forearm fracture (Colle’s), vertebral fracture | 263 | list | 0.820 | Ultrasound abdomen, gall stones, renal stones and nephrocalcinosis, Ultrasound neck, enlarged parathyroid Sestamibi scan for parathyroid enlargement • To be suspected in fractures resulting from trivial trauma or fall from a standing height or less • For example fracture neck of femur, forearm fracture (Colle’s), vertebral fracture | 1 | page=1,block=6 | 0.700 | valid |
| What is the prescribed dose and method of administration for Zoledronic acid? | Inj Zoledronic acid 5mg I/V infusion | • Daily oral calcium 1-1.5 gm/day • Vitamin D supplementation to maintain serum 25OHD levels of 30.0-50 ng/ml • Stop smoking alcohol • Inj Zoledronic acid 5mg I/V infusion OR • Inj Denosumab 60mg S/C every 6 months OR • Inj rPTH 20 µg S/C daily for maximum 2 years CKD: Chronic kidney disease rPTH: recombinant Parathyroid hormone CLD: Chronic liver disease | 135 | factual | 0.570 | • Daily oral calcium 1-1.5 gm/day • Vitamin D supplementation to maintain serum 25OHD levels of 30.0-50 ng/ml • Stop smoking alcohol • Inj Zoledronic acid 5mg I/V infusion OR • Inj Denosumab 60mg S/C every 6 months OR • Inj rPTH 20 µg S/C daily for maximum 2 years CKD: Chronic kidney disease rPTH: recombinant Parathyroid hormone CLD: Chronic liver disease | 1 | page=1,block=41 | 0.700 | valid |
| What is the longest period that recombinant parathyroid hormone can be administered daily? | maximum 2 years | • Daily oral calcium 1-1.5 gm/day • Vitamin D supplementation to maintain serum 25OHD levels of 30.0-50 ng/ml • Stop smoking alcohol • Inj Zoledronic acid 5mg I/V infusion OR • Inj Denosumab 60mg S/C every 6 months OR • Inj rPTH 20 µg S/C daily for maximum 2 years CKD: Chronic kidney disease rPTH: recombinant Parathyroid hormone CLD: Chronic liver disease | 249 | factual | 0.490 | • Daily oral calcium 1-1.5 gm/day • Vitamin D supplementation to maintain serum 25OHD levels of 30.0-50 ng/ml • Stop smoking alcohol • Inj Zoledronic acid 5mg I/V infusion OR • Inj Denosumab 60mg S/C every 6 months OR • Inj rPTH 20 µg S/C daily for maximum 2 years CKD: Chronic kidney disease rPTH: recombinant Parathyroid hormone CLD: Chronic liver disease | 1 | page=1,block=41 | 0.700 | valid |
| How often is Denosumab administered? | every 6 months | • Daily oral calcium 1-1.5 gm/day • Vitamin D supplementation to maintain serum 25OHD levels of 30.0-50 ng/ml • Stop smoking alcohol • Inj Zoledronic acid 5mg I/V infusion OR • Inj Denosumab 60mg S/C every 6 months OR • Inj rPTH 20 µg S/C daily for maximum 2 years CKD: Chronic kidney disease rPTH: recombinant Parathyroid hormone CLD: Chronic liver disease | 200 | factual | 0.450 | • Daily oral calcium 1-1.5 gm/day • Vitamin D supplementation to maintain serum 25OHD levels of 30.0-50 ng/ml • Stop smoking alcohol • Inj Zoledronic acid 5mg I/V infusion OR • Inj Denosumab 60mg S/C every 6 months OR • Inj rPTH 20 µg S/C daily for maximum 2 years CKD: Chronic kidney disease rPTH: recombinant Parathyroid hormone CLD: Chronic liver disease | 1 | page=1,block=41 | 0.700 | valid |
Read straight from the file — download or use the API URL for the full dataset.